:

Sheena Bhalla1,2, Sofia Yi3, David E Gerber1,2,4

  • 1Department of Internal Medicine (Division of Hematology-Oncology), UT Southwestern Medical Center, Dallas, TX, United States.

Clinical chemistry
|January 4, 2024
PubMed
概括

新的生物标志物旨在提高肺癌查 (LCS) 的准确性. 血液,呼吸和尿液测试正在开发中,以补充低剂量计算机断层扫描 (LDCT) 以更好地早期检测和风险评估.